These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1895044)

  • 1. Antihypertensive efficacy and tolerability of enalapril and slow-release verapamil in essential hypertension: a double-blind, cross-over study.
    Fagher B; Katzman P; Hulthén UL; Henningsen NC; Thulin T
    J Intern Med; 1991 Sep; 230(3):219-26. PubMed ID: 1895044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive and renal effects of enalapril and slow-release verapamil in essential hypertension. A double-blind, randomized study.
    Fagher B; Henningsen N; Hulthén L; Katzman P; Thulin T
    Eur J Clin Pharmacol; 1990; 39 Suppl 1():S41-3. PubMed ID: 2261943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of enalapril and sustained-release verapamil in older patients with mild to moderate essential hypertension.
    Weir MR; Cassidy CA; Hall PS; Lancaster A; Schubert C; Urick A; Saunders E; Kong BW; Jenkins P; Lavin PT
    Clin Ther; 1990; 12(2):139-48. PubMed ID: 2354483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising.
    White WB; Sica DA; Calhoun D; Mansoor GA; Anders RJ
    Am Heart J; 2002 Oct; 144(4):657-65. PubMed ID: 12360162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative trial of controlled-onset, extended-release verapamil, enalapril, and losartan on blood pressure and heart rate changes.
    Bakris G; Sica D; Ram V; Fagan T; Vaitkus PT; Anders RJ
    Am J Hypertens; 2002 Jan; 15(1 Pt 1):53-7. PubMed ID: 11824861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the efficacy and tolerability of lisinopril and sustained-release verapamil in older patients with hypertension.
    Weir MR; Lavin PT
    Clin Ther; 1991; 13(3):401-8. PubMed ID: 1659494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid profile during antihypertensive treatment. The SLIP Study Group. Study on Lipids with Isoptin Press.
    Libretti A; Catalano M
    Drugs; 1993; 46 Suppl 2():16-23. PubMed ID: 7512469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of a new long-acting drug combination, trandolapril/verapamil as compared to monotherapy in primary hypertension. Swedish TARKA trialists.
    Karlberg BE; Andrup M; Odén A
    Blood Press; 2000; 9(2-3):140-5. PubMed ID: 10855738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of candesartan versus enalapril in essential hypertension. Italian Candesartan Study Group.
    Zanchetti A; Omboni S
    Am J Hypertens; 2001 Feb; 14(2):129-34. PubMed ID: 11243303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enalapril and verapamil in the treatment of isolated systolic hypertension in the elderly.
    Espinel CH; Bruner DE; Davis JR; Williams JL
    Clin Ther; 1992; 14(6):835-44. PubMed ID: 1286492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of arterial hypertension in the aged subject with a converting enzyme inhibitor: enalapril].
    Forette F; Handfield-Jones R; Henry-Amar M; Fouchard M; Bouchacourt P; Hervy MP; Henry JF; Mesguisch-Billaud E; Alexandre JM
    Presse Med; 1985 Dec; 14(44):2237-41. PubMed ID: 3003729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of telmisartan, a selective AT1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension. TEES Study Group.
    Karlberg BE; Lins LE; Hermansson K
    J Hypertens; 1999 Feb; 17(2):293-302. PubMed ID: 10067800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double blind comparative study of lisinopril and enalapril in patients with essential hypertension.
    Johnston GD; Banks DC; Davies S; Duffin D; Garnham JC; Nicholls DP; Raj MV; Mansy S; Sloan P; Strouthidis TM
    J Hum Hypertens; 1991 Oct; 5(5):405-10. PubMed ID: 1663163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender and age effects on the ambulatory blood pressure and heart rate responses to antihypertensive therapy.
    White WB; Johnson MF; Black HR; Elliott WJ; Sica DA
    Am J Hypertens; 2001 Dec; 14(12):1239-47. PubMed ID: 11775133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of mild to moderate hypertension with or without the converting enzyme inhibitor enalapril. Results of a six-month double-blind trial.
    Sassano P; Chatellier G; Billaud E; Alhenc-Gelas F; Corvol P; Ménard J
    Am J Med; 1987 Aug; 83(2):227-35. PubMed ID: 3039842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal and endocrine effects of long-term converting enzyme inhibition as compared with calcium antagonism in essential hypertension.
    Katzman PL; Henningsen NC; Fagher B; Thulin T; Hulthén UL
    J Cardiovasc Pharmacol; 1990 Mar; 15(3):360-4. PubMed ID: 1691357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and tolerability of enalapril in a formulation with a very low dose of hydrochlorothiazide in hypertensive patients resistent to enalapril monotherapy.
    Guul SJ; Os I; Jounela AJ
    Am J Hypertens; 1995 Jul; 8(7):727-31. PubMed ID: 7546499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacy and tolerability of lisinopril and sustained-release verapamil in black patients with hypertension.
    Weir MR; Kong BW; Jenkins P; Lavin PT
    Clin Ther; 1991; 13(3):409-16. PubMed ID: 1659495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind, parallel, comparative study on quality of life during treatment with amlodipine or enalapril in mild or moderate hypertensive patients: a multicentre study.
    Omvik P; Thaulow E; Herland OB; Eide I; Midha R; Turner RR
    J Hypertens; 1993 Jan; 11(1):103-13. PubMed ID: 8382234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twenty-four hour blood pressure effect of once-daily lisinopril, enalapril, and placebo in patients with mild to moderate hypertension.
    Whelton A; Dunne B; Glazer N; Kostis JB; Miller WE; Rector DJ; Tresznewsky ON
    J Hum Hypertens; 1992 Aug; 6(4):325-31. PubMed ID: 1331444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.